Clinical medications development for opiate addiction: Focus on nonopioids and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention

被引：23
作者：
Herman, BH
O'Brien, CP
机构：
[1] NIDA, Clin Trials Branch, Medicat Dev Div, NIH, Rockville, MD 20857 USA
[2] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
来源：
SEMINARS IN NEUROSCIENCE | 1997年 / 9卷 / 3-4期
关键词：
D O I：
10.1006/smns.1997.0115
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 172
页数：15
相关论文
共 125 条
[11]  
BATKI S L, 1990, Journal of Clinical Psychopharmacology, V10, p111S
[12]   Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal [J].
Bearn, J ;
Gossop, M ;
Strang, J .
DRUG AND ALCOHOL DEPENDENCE, 1996, 43 (1-2) :87-91
[13]  
BRADWEJN J, 1994, ARCH GEN PSYCHIAT, V51, P486
[14]   OPIOID WITHDRAWAL AND NALTREXONE INDUCTION IN 48-72 HOURS WITH MINIMAL DROP-OUT, USING A MODIFICATION OF THE NALTREXONE-CLONIDINE TECHNIQUE [J].
BREWER, C ;
REZAE, H ;
BAILEY, C .
BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 :340-343
[15]  
CHARNEY DS, 1981, ARCH GEN PSYCHIAT, V38, P1273
[16]  
CHARNEY DS, 1986, AM J PSYCHIAT, V143, P831
[17]  
CHARNEY DS, 1982, ARCH GEN PSYCHIAT, V39, P1327
[18]  
CHEN HSV, 1992, J NEUROSCI, V12, P4427
[19]  
Childress AR., 1992, SUBSTANCE ABUSE COMP, P56
[20]   A PLACEBO-CONTROLLED EVALUATION OF THE EFFECTS OF BUSPIRONE ON SMOKING CESSATION - DIFFERENCES BETWEEN HIGH-ANXIETY AND LOW-ANXIETY SMOKERS [J].
CINCIRIPINI, PM ;
LAPITSKY, L ;
SEAY, S ;
WALLFISCH, A ;
MEYER, WJ ;
VANVUNAKIS, H .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (03) :182-191
12345678910